Prothena Corp Public (PRTA) Total Non-Current Liabilities (2013 - 2026)

Prothena Corp Public (PRTA) recorded quarterly Total Non-Current Liabilities of $4.8 million in Q1 2026, down 13.23% quarter-over-quarter from $5.5 million in Q4 2025, and down 48.23% on a YoY basis from $9.2 million in Q1 2025.

Prothena Corp Public (PRTA) Total Non-Current Liabilities (2013 - 2026) Analysis & Trends

Prothena Corp Public's Total Non-Current Liabilities history runs 14 years deep, the most recent figure standing at $4.8 million for Q1 2026.

  • In Q1 2026, Total Non-Current Liabilities fell 48.23% year-over-year to $4.8 million; the TTM figure through Mar 2026 stood at $4.8 million (down 48.23% YoY), while the FY2025 annual figure was $5.5 million, down 53.03% from the prior year.
  • Total Non-Current Liabilities was $4.8 million for Q1 2026 at Prothena Corp Public, down from $5.5 million in the prior quarter.
  • In the past five years, Total Non-Current Liabilities ranged from a high of $106.0 million in Q1 2022 to a low of $4.8 million in Q1 2026.
  • Historically, Total Non-Current Liabilities has averaged $50.2 million across 5 years, with a median of $67.4 million in 2023.
  • The sharpest annual moves came in 2022 and 2025: Total Non-Current Liabilities climbed 7.25% in 2022, then plunged 88.14% in 2025.
  • A 5-year view of Total Non-Current Liabilities shows it stood at $85.8 million in 2022, then dropped by 8.99% to $78.1 million in 2023, then plunged by 85.05% to $11.7 million in 2024, then slumped by 53.03% to $5.5 million in 2025, then slipped by 13.23% to $4.8 million in 2026.
  • The last three Total Non-Current Liabilities figures came in at $4.8 million (Q1 2026), $5.5 million (Q4 2025), and $6.2 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Non-Current Liabilities (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - 42,980.09
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - 11.03 Mn
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn 95.20 Mn
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - -
7 Psyence Biomedical 212.16 Bn 212.16 Bn - 644,700.00
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn 5.87 Bn
9 Abivax 91.96 Bn 91.96 Bn - 64.76 Mn
10 Prothena Corp Public 479.08 Mn 149.61 Mn - 4.76 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 4.76 Mn
Dec 31, 2025 5.49 Mn
Sep 30, 2025 6.20 Mn
Jun 30, 2025 6.93 Mn
Mar 31, 2025 9.20 Mn
Dec 31, 2024 11.68 Mn
Sep 30, 2024 14.47 Mn
Jun 30, 2024 16.90 Mn
Mar 31, 2024 77.53 Mn
Dec 31, 2023 78.13 Mn
Sep 30, 2023 76.32 Mn
Jun 30, 2023 67.41 Mn
Mar 31, 2023 85.29 Mn
Dec 31, 2022 85.85 Mn
Sep 30, 2022 99.19 Mn
Jun 30, 2022 102.18 Mn
Mar 31, 2022 106.03 Mn
Dec 31, 2021 109.87 Mn
Sep 30, 2021 113.03 Mn
Jun 30, 2021 95.27 Mn